Effect of interlimb-coordinated training on pulmonary function in patients with early primary Parkinson's disease
10.3969/j.issn.1006-9771.2022.08.012
- VernacularTitle:肢体协调训练对早期原发性帕金森病患者肺功能的效果
- Author:
Jieping WANG
1
;
Juan PENG
1
;
Feixue ZHANG
1
;
Bishuang FAN
1
;
Fangyuan XU
1
Author Information
1. Department of Rehabilitation, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China
- Publication Type:Journal Article
- Keywords:
early primary Parkinson's disease;
interlimb-coordinated training;
pulmonary function
- From:
Chinese Journal of Rehabilitation Theory and Practice
2022;28(8):966-971
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo observe the effect of interlimb-coordinated training on pulmonary function in patients with early primary Parkinson's disease. MethodsFrom February, 2021 to February, 2022, 60 patients with primary Parkinson's disease in Affiliated Hospital of Southwest Medical University were divided into control group (n = 30) and experimental group (n = 30) according to the management, who accepted medicine and medicine combined with interlimb-coordinated training, for twelve weeks, respectively. Before and after treatment, the forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), maximum expiratory flow (PEF) and vital capacity (VC) were measured with pulmonary function instrument, while the peak oxygen uptake (VO2peak), anaerobic threshold (AT) and peak power (WRpeak) were measured with Cardiopulmonary Exercise Test (CPET), and the maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) were measured with respiratory driving instrument. ResultsAfter treatment, FEV1, FVC, PEF, VC, VO2peak, AT, WRpeak, MIP and MEP increased in the experimental group (t > 2.087, P < 0.05), and they were more in the experimental group than in the control group (t > 2.079, P < 0.05). ConclusionInterlimb-coordinated training could improve the pulmonary function, aerobic exercise ability and respiratory muscle strength of patients with early primary Parkinson's disease.
